Giles K, et al. Real-world efficacy of delayed-release dimethyl fumarate in early multiple sclerosis: interim results from ESTEEM. ECTRIMS 2018, P595.
EU-goedkeuring voor ofatumumab bij relapsing MS
apr 2021 | Multipele Sclerose
jan 2024 | Neuro-vasculair
dec 2023 | Bewegingsstoornissen